Mexico slaps Lilly, Baxter with price-fixing fines

Six pharmaceutical companies--including Eli Lilly's Mexican unit and Baxter Healthcare--were fined more than 150 million pesos ($11.6 million) for conspiring to raise the price of medicines they sold to a social-services agency, Mexico's anti-monopoly commission said. Report

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.